Document is current
Any future updates will be listed below
-
Authors
Hendriksen, Heleen M.A.
de Rijke, Tanja J.
van Gils, Aniek M.
de Beer, Marlijn H.
Bouwman, Femke H.
Diaz, Ana
Fluitman, Tjeerd
Hempenius, Liesbeth
van Maurik, Ingrid S.
Pel-Littel, Ruth E.
Rhodius-Meester, Hanneke F.M.
Roks, Gerwin
Smets, Ellen M.A.
van der Flier, Wiesje M.
Visser, Leonie N.C.
-
Funding
Funding for this research was provided by:
Horizon Europe IHI project (#101112145, #101112145)
ZonMw (#73305095007, #73305095007, #73305095007)
Health~Holland, Topsector Life Sciences & Health (#LSHM20106, #LSHM20106, #LSHM20106)
EU Joint Programme – Neurodegenerative Disease Research (#10510062210005)
Innovative Health Initiative Joint Undertaking (101132933)
- License Information
-
More Information
Article History
Received: 18 March 2025
Accepted: 13 August 2025
First Online: 2 October 2025
Declarations
:
: The study was approved by the board of the Medical Ethics Committee of the VU Medical Center, Amsterdam UMC and the local Medical Ethical Committee in all four participating medical centers. All patients provided written informed consent to participate and for their data to be used for research purposes.
: Not applicable.
: HH, TR, AvG, MdB, FB, AD, TF, LH, IvM, RPL, HRM, GR, and ES report no financial disclosures or conflicts of interest. Leonie Visser (LNCV) has been an invited speaker at Schwabe Group, fees were paid to her institution. Her research has been funded by ZonMW, Alzheimer Nederland, Health~Holland Topsector Life Sciences & Health, Eisai, and Amsterdam public health research institute. Research programs of Wiesje van der Flier have been funded by ZonMW, NWO, EU-JPND, EU-IHI, Alzheimer Nederland, Hersenstichting CardioVascular Onderzoek Nederland, Health~Holland, Topsector Life Sciences & Health, stichting Dioraphte, Gieskes-Strijbis fonds, stichting Equilibrio, Edwin Bouw fonds, Pasman stichting, stichting Alzheimer & Neuropsychiatrie Foundation, Philips, Biogen MA Inc, Novartis-NL, Life-MI, AVID, Roche BV, Fujifilm, Eli-Lilly-NL, Eisai, Combinostics. WF holds the Pasman chair. WF is recipient of ABOARD, which is a public-private partnership receiving funding from ZonMW (#73305095007) and Health~Holland, Topsector Life Sciences & Health (PPP-allowance; #LSHM20106). WF is recipient of TAP-dementia (), receiving funding from ZonMw (#10510032120003). TAP-dementia receives co-financing from Avid Radiopharmaceuticals and Amprion. All funding is paid to her institution. WF has been an invited speaker at Biogen MA Inc, Danone, Eisai, WebMD Neurology (Medscape), NovoNordisk, Springer Healthcare, European Brain Council. All funding is paid to her institution. WF is consultant to Oxford Health Policy Forum CIC, Roche, Biogen MA Inc, and Eisai. All funding is paid to her institution. WF participated in advisory boards of Biogen MA Inc, Roche, and Eli Lilly. WF is member of the steering committee of EVOKE/EVOKE+ (NovoNordisk). All funding is paid to her institution. WF is member of the steering committee of PAVE, and Think Brain Health. WF was associate editor of Alzheimer, Research & Therapy in 2020/2021. WF is associate editor at Brain.
